ATiO Foundation partners with OARSI to fight osteoarthritis
The Advanced Therapies in Orthopaedics Foundation (ATiO) has recently announced an exciting new partnership with the Osteoarthritis Research Society International (OARSI). This collaboration brings together leading global experts from all professions in orthopaedics and osteoarthritis to foster innovation in advanced therapies for joint diseases.
The ATiO Foundation, associated with the Charité – Universitätsmedizin Berlin and the BIH Center for Regenerative Therapies (BCRT), focuses on accelerating translation for advanced therapies with musculoskeletal indications through a unique network of key opinion leaders representing researchers, clinicians and industry partners. On the other hand, OARSI is one of the leading forces dedicated to improving the education, research, treatment and prevention of osteoarthritis, a growing global health concern.
Prof. Winkler, Co-founder of the ATiO and head of advanced musculoskeletal therapies @ Berlin Institute of Health Center for Regenerative Therapies and @ Center for Musculoskeletal Surgery, emphasizes the importance of this partnership in pushing forward cutting-edge solutions for patients suffering from osteoarthritis, one of the leading disease burdens of the musculoskeletal system.
“Our joint efforts with OARSI open new avenues for innovative therapies in osteoarthritis, focusing on translating breakthroughs into effective clinical treatments.” - Prof. Dr. Tobias Winkler
Prof. Dr. Georg Duda, speaker of the BCRT, director of the JWI of the BIH and member of the ATiO Board, highlights the role of the OARSI.
“The OARSI is the world leading osteoarthritis organisation and we are more than happy to share our impact also on the guideline level.” - Prof. Dr. Georg Duda
Dr. Doris Meder, Acting Administrative Director at BIH and a member of the ATiO Board, highlights the collaboration’s potential for translating research into real-world clinical applications.
“By uniting the forces of both societies, we are aiming to drive forward meaningful change for osteoarthritis patients.” – Dr. Doris Meder
This partnership will focus on combining OARSI’s expertise in osteoarthritis with ATiO’s network and competences in the field of advanced therapies to push the boundaries of new treatments and personalized medicine. Together, these organizations aim to create a pipeline of solutions that will not only slow the progression of osteoarthritis but also aim to find a cure.
For more information on the societies, visit ATiO Foundation and OARSI.